Israeli student develops drug-delivering skin gel; Nanorobots offer delivery at the atomic level;

> A student at the Hebrew University of Jerusalem has developed a gel made of lyotropic liquid crystals for the application of drugs directly to the skin where oral drugs can cause severe side effects. Marganit Cohen-Avrahami won one of this year's Kaye Innovation Awards for her work. Report

> Scientific American, in its "30 Under 30" report highlighting young scientists, interviewed Aniket Magarkar, who studies liposomes that could help develop nanorobots capable of delivering drugs. Report

> Alchemy Pharmatech snagged a £400,000 investment from the North West Fund for its intranasal drug-delivery system for DNA vaccines, hormone replacement compounds and pain-control products. Release

> Access Pharmaceuticals ($ACCP) signed a licensing agreement with AMAG Pharmaceuticals ($AMAG) for $3.3 million to market its MuGard, a mucoadhesive treatment for oral wounds. Release

> Discovery Labs ($DSCO) presented an analysis that showed its Surfaxin treatment for infant respiratory distress syndrome, the first synthetic, peptide-containing surfactant approved by the FDA, could save up to $562,000 per 100 patients. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.